Free Trial

HC Wainwright's Rating of Dogwood Therapeutics on 9/30/2025

On September 30, 2025, HC Wainwright updated its outlook on Dogwood Therapeutics (NASDAQ:DWTX) with the action "Boost Price Target", setting a price target of $12.00. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from HC Wainwright

DateCompanyAction
10/10/2025
Applied Digital Corporation stock logo
APLD
Applied Digital
Boost Price Target
10/10/2025
McEwen Inc. stock logo
MUX
McEwen
Boost Price Target
10/10/2025
WISeKey International Holding Ltd. Sponsored ADR stock logo
WKEY
WISeKey International
Boost Price Target
10/10/2025
BlackSky Technology Inc. stock logo
BKSY
BlackSky Technology
Boost Price Target
10/10/2025
Cabaletta Bio, Inc. stock logo
CABA
Cabaletta Bio
Reiterated Rating
10/10/2025
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
Reiterated Rating
More Ratings From HC Wainwright